Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytesCarissa R Moore, Gail A BishopJournal of Cancer Science & Therapy|May 12, 2015
Targeting TRAF3 Downstream Signaling Pathways in B cell NeoplasmsCarissa R Moore, Shanique Ke Edwards, Ping XieJournal of Immunology (Baltimore, Md. : 1950)|August 12, 2009
Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1John P Graham, Carissa R Moore, Gail A BishopGenomics Data|November 25, 2014
Transcriptomic profiling of splenic B lymphomas spontaneously developed in B cell-specific TRAF3-deficient micePing Xie, Carissa R Moore, Mavis R Swerdel, et al.Leukemia Research|January 15, 2014
Expression and function of a novel isoform of Sox5 in malignant B cellsShanique K E Edwards, Anand Desai, Yan Liu, et al.Advances in Experimental Medicine and Biology|July 18, 2007
TRAF proteins in CD40 signalingGail A Bishop, Carissa R Moore, Ping Xie, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signalingPing Xie, Bruce S Hostager, Melissa E Munroe, et al.BMC Cancer|October 18, 2013
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myelomaShanique K E Edwards, Carissa R Moore, Yan Liu, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2014
Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in miceAlmin I Lalani, Carissa R Moore, Chang Luo, et al.Journal of Hematology & Oncology|September 10, 2014
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytesShanique K E Edwards, Jacqueline Baron, Carissa R Moore, et al.Pageof 2